This applies to both injectable and oral GLP-1 formulations
Liepinsh E, Makrecka-Kuka M, Makarova E, Volska K, Svalbe B, Sevostjanovs E, et al
(North America, Europe, APAC, Latin America, Middle East and Africa) Industry Analysis From 2025 to 2033 The global semaglutide market was valued at USD 110 million in 2024
Anesthesia: Not required
Hence, when TD is limited to the gastrointestinal system, the pathology-relevant perturbation of ACh signaling may rather be expected in the enteric nervous system (ENS)
Various general autoantibodies have also been identified in ME/CFS, such as those against cellular components including anchorage molecules (514), HSP-60 (515), microtubule associated protein 2 (516), cardiolipin in 92-95% of ME/CFS patients in two studies (509, 510) but only 4% in another study (506), and neo-antigens (517)